Our Medicines - Serving Patients
We are proud to offer innovative prescription and non-prescription medicines for a wide range of conditions.
The following are the products of Boehringer Ingelheim (Canada) Ltd./Ltée. The information contained in the links is intended for Canadian healthcare professionals and patients.
Our Products
| Brand Name | Product Monograph | Consumer Information |
| Aggrenox | Download | Download |
| Aptivus | Download | Download |
| Atrovent HFA | Download | Download |
| Basaglar | Download | Download |
| Combivent Respimat | Download | Download |
| Combivent UDV | Download | Download |
| Flomax CR | Download | Download |
| Giotrif | Download | Download |
| Glyxambi | Download | Download |
| Inspiolto Respimat | Download | Download |
| Jardiance | Download | Download |
| JentaDueto | Download | Download |
| Micardis | Download | Download |
| Micardis Plus | Download | Download |
| Mirapex | Download | Download |
| Mobicox | Download | Download |
| Ofev | Download | Download |
| Persantine | Download | Download |
| Pradaxa (New Name) | Download | Download |
| Praxbind | Download | Download |
| Spiriva | Download | Download |
| Spiriva Respimat | Download | Download |
| Striverdi Respimat | Download | Download |
| Synjardy | Download | Download |
| Trajenta | Download | Download |
| Twynsta | Download | Download |
| Viramune | Download | Download |
Medications Return Programs
The Medications Return Programs are the safe and easy way to dispose of drugs we all have in our homes. The purpose is to collect unused or expired medications from the public before they are disposed of in the garbage or poured down sewers and drains.
For more information and to locate a safe disposal drop-off location near you, visit www.healthsteward.ca
Important information regarding Pradaxa® (dabigatran etexilate)
| November 2011 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| December 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| March 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
Important information regarding Ofev® (nintedanib)
| January 2018 | |
| Dear Healthcare Professionnal Letter | View document |